Table 3: Referral indication for OGD and diagnostic yield according to ASGE guideline criteria
| ASGE indication of referral | Overall, % (n = 1,019) | Relevant lesion, % | LR+ | LR– | |||||
| • Appropriate indication | |||||||||
| 1. Upper abdominal symptoms persistent despite therapy | 11.8 | 66.7 | 1.91 | 0.92 | |||||
| 2. Upper abdominal symptoms associated with symptoms and signs suggesting serious organic disease or in patients aged >45 years | 7.9 | 91.3 | 9.96 | 0.87 | |||||
| 3. Esophageal reflux symptoms persistent or recurrent despite therapy | 2.9 | 76.7 | 3.14 | 0.96 | |||||
| 4. Portal hypertension evaluation | 0.5 | 100 | 10.51 | 0.99 | |||||
| 5. Active or recent GI bleeding | 12.9 | 53.4 | 1.09 | 0.98 | |||||
| 6. Suspected chronic bleeding | 4.9 | 56 | 1.21 | 0.99 | |||||
| 7. Dysphagia or odynophagia | 7.3 | 52.7 | 1.06 | 0.99 | |||||
| 8. GI assessment in other medical disorders | 2.0 | 55 | 1.16 | 0.99 | |||||
| 9. Persistent vomiting of unknown cause | 3.9 | 80 | 3.82 | 0.95 | |||||
| 10. Sclerotherapy or variceal bleeding | 0.5 | 100 | 10.51 | 0.99 | |||||
| 11. Histologic assessment of a neoplasia detected radiologically | 1.0 | 60 | 1.43 | 0.99 | |||||
| 12. Others | 2.6 | 46.2 | 0.81 | 1 | |||||
| 13. Total | 58 | 65 | 1.77 | 0.45 | |||||
| • Not appropriate indications | |||||||||
| 1. Symptoms considered functional | 17 | 38.7 | 0.64 | 1.32 | |||||
| 2. Surveillance of healed benign lesions | 22 | 25.9 | 0.33 | 1.33 | |||||
| 3. Others | 3.0 | 38.7 | 0.64 | 1.01 | |||||
| 4. Total | 42 | 32 | 0.45 | 1.77 |
GI: Gastrointestinal